Sunday, 22 December 2024

  1. Poll
  2. COVID-19

Poll

COVID-19

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

Yes68%
68% Complete
No15%
15% Complete
May Be16%
16% Complete
  More polls

Leadership

image credit- shutterstock

BioPharma’s Transformative & S...

Innovations in Urological Imag...
image credit- shutterstock

What’s dampening the Global AM...

Indian Lifesciences Industry G...
image credit- shutterstock

HIV Prevention Remains Elusive...

How strategic angel investment...

TRENDING TOPICS

image credit- shutterstock

Early Diabetic Retinopathy Det

Impact of Digital Transformati
image credit- pib

Govt announces launch of 4 CoE

PM inaugurates Lyfius Pharma’s





Most read

UCL and IISc join forces to co-crea

Medtronic launches US FDA approved

IIT Kharagpur partners with z21 Ven

Samsung R&D Institute, Noida and II

Survey Box

Is the Indian BioPharma sector ready for a Transformative & Strategic Outlook in 2025?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls

Subscribe to BioSpectrum India

Enquiry

Contact Us

MMA

Ashirwad Bungalow, First floor,
36/A/2, S.No. 270, Pallod Farms,
Near Bank of Baroda, Baner Road,
Pune, Maharashtra, India 411045

Mob : +91-9579069369

Email : communications@mmactiv.com

**Disclaimer

Visit Our Digital Magazine :

BioSpectrum Asia

NuFFooDS Spectrum

Sitemap

© 2024 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer

Web Interface Conceived and Powered By : SCI Knowledge Interlinks